Coegin Pharma advanced its FOL005 hair growth project, secured new partnerships, and improved operating results year-over-year, with financing secured into Q1 2025 and a dual-listing on Börse Stuttgart.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
